Fundraising Fox
Kimialys
4 known investors
Find your way into Kimialys
Sign up to find every way you can get introduced to Kimialys
- Your email: who you already know at Kimialys, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kimialys team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
Investors · 4
In the news
Frequently asked questions
- What does Kimialys do?
- Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
- Who are Kimialys's investors?
- Kimialys's investors include Angels Santé, Octalfa, Super Capital VC, Turenne Capital Partenaires.